---
title: "Neuphoria Therapeutics Soars 17% on Scancell All-Stock Merger Deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293656632.md"
description: "Neuphoria Therapeutics jumped 17% in regular trading after announcing an all-stock merger with Scancell."
datetime: "2026-07-23T19:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293656632.md)
  - [en](https://longbridge.com/en/news/293656632.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293656632.md)
generator: "portal-rs"
---

# Neuphoria Therapeutics Soars 17% on Scancell All-Stock Merger Deal

Neuphoria Therapeutics(NEUP.US) 盘中涨**17.42%**，现报**3.91 美元**。

公司宣布与 Scancell 进行全股票合并交易，推动股价大幅上涨。该股在常规交易时段曾一度跳涨**23%**，随后涨幅有所收窄。消息发布于 07/23/2026，显示生物医药板块 intraday 交易中多只个股出现显著波动。

### Related Stocks

- [NEUP.US](https://longbridge.com/en/quote/NEUP.US.md)

## Related News & Research

- [Oil rebounds after Trump rejects Iran peace deal](https://longbridge.com/en/news/300229709.md)
- [Satya Nadella Says Xbox Is on Track for a Comeback After Major Layoffs — ‘I Feel Fantastic’ About Its Gaming IP](https://longbridge.com/en/news/300308967.md)
- [MaxLinear (MXL) Draws Fresh Attention, Does It Look Fully Valued?](https://longbridge.com/en/news/300242448.md)
- [China’s consumer stocks face lost decade](https://longbridge.com/en/news/300225845.md)
- [GRAPHIC-Take Five: It's Q4 already?](https://longbridge.com/en/news/300262226.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**